dc.creator | Torrealba J.I., Spanos K., Panuccio G., Rohlffs F., Gandet T., Heidemann F., Tsilimparis N., Kölbel T. | en |
dc.date.accessioned | 2023-01-31T10:08:58Z | |
dc.date.available | 2023-01-31T10:08:58Z | |
dc.date.issued | 2022 | |
dc.identifier | 10.1177/15266028211058682 | |
dc.identifier.issn | 15266028 | |
dc.identifier.uri | http://hdl.handle.net/11615/79729 | |
dc.description.abstract | Purpose: The purpose of this study was to evaluate early and mid-term results of non-standard management of the supraaortic target vessels with the use of the inner branch arch endograft in a single high-volume center. Material and methods: A single-center retrospective study including all patients undergoing implantation of an inner branch arch endograft from December 2012 to March 2021, who presented a non-standard management of the supraaortic target vessels (any bypass other than a left carotid-subclavian or landing in a dissected target vessel). Technical success, mortality, reinterventions, endoleak (EL), and aortic remodeling at follow-up were analyzed. Results: Twenty-four patients were included. In 17 (71%) cases, the non-standard management was related to innominate artery (IA) compromise (12 with IA dissection, 2 with short IA, 2 with short proximal aortic landing zone that required occlusion of IA, 1 with occluded IA after open arch repair). Two (8%) cases were related to an aberrant right subclavian artery (RSA), 1 patient (4%) due to the concomitant presence of a left vertebral artery (LVA) arising from the arch and an occluded left subclavian artery (LSA), and another patient presented with an occluded LSA distal to a dominant vertebral artery. Three (13%) cases were exclusively related to management in patients with genetic aortic syndromes. Twenty (83%) patients had a previous type A aortic dissection. Ten (42%) patients presented a thoracic or thoracoabdominal aortic aneurysm and 8 (33%) patients an arch aneurysm, 6 of them associated to false lumen (FL) perfusion. There were 2 (8%) perioperative minor strokes, and 1 patient with perioperative mortality. Seven patients presented an early type I endoleak, all resolved at follow-up. Seven patients required reinterventions during follow-up (7 reinterventions related to continuous false lumen perfusion, 3 related to Type Ia endoleak, 2 related to surgical bypass). All patients who presented with FL perfusion had complete FL thrombosis at follow-up. No patient presented aneurysm growth at follow-up. Conclusions: The use of the inner branch arch endograft with a non-standard management of the supraaortic target vessels is a possible option. Despite a high reintervention rate, regression or stability of the aneurysmal diameter was achieved in all the patients with follow-up. © The Author(s) 2021. | en |
dc.language.iso | en | en |
dc.source | Journal of Endovascular Therapy | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85119398159&doi=10.1177%2f15266028211058682&partnerID=40&md5=f83b8805a1de7be215e91e9dd8dcf970 | |
dc.subject | adult | en |
dc.subject | aged | en |
dc.subject | aortic arch aneurysm | en |
dc.subject | aortic dissection | en |
dc.subject | aortic occlusion | en |
dc.subject | arterial embolization | en |
dc.subject | Article | en |
dc.subject | brachiocephalic trunk | en |
dc.subject | carotid artery stenting | en |
dc.subject | cerebrovascular accident | en |
dc.subject | chronic obstructive lung disease | en |
dc.subject | coronary artery bypass graft | en |
dc.subject | coronary artery disease | en |
dc.subject | demographics | en |
dc.subject | diabetes mellitus | en |
dc.subject | endoleak | en |
dc.subject | female | en |
dc.subject | follow up | en |
dc.subject | heart failure | en |
dc.subject | heart surgery | en |
dc.subject | human | en |
dc.subject | hypertension | en |
dc.subject | left common carotid artery | en |
dc.subject | left subclavian artery | en |
dc.subject | major clinical study | en |
dc.subject | male | en |
dc.subject | management | en |
dc.subject | middle aged | en |
dc.subject | mortality | en |
dc.subject | outcome assessment | en |
dc.subject | perfusion | en |
dc.subject | retrospective study | en |
dc.subject | right subclavian artery | en |
dc.subject | surgical mortality | en |
dc.subject | thoracic aorta aneurysm | en |
dc.subject | thoracoabdominal aorta aneurysm | en |
dc.subject | vertebral artery | en |
dc.subject | blood vessel prosthesis | en |
dc.subject | blood vessel transplantation | en |
dc.subject | diagnostic imaging | en |
dc.subject | dissecting aneurysm | en |
dc.subject | endoleak | en |
dc.subject | endovascular surgery | en |
dc.subject | thoracic aorta | en |
dc.subject | thoracic aorta aneurysm | en |
dc.subject | time factor | en |
dc.subject | treatment outcome | en |
dc.subject | Aneurysm, Dissecting | en |
dc.subject | Aorta, Thoracic | en |
dc.subject | Aortic Aneurysm, Thoracic | en |
dc.subject | Blood Vessel Prosthesis | en |
dc.subject | Blood Vessel Prosthesis Implantation | en |
dc.subject | Endoleak | en |
dc.subject | Endovascular Procedures | en |
dc.subject | Humans | en |
dc.subject | Retrospective Studies | en |
dc.subject | Time Factors | en |
dc.subject | Treatment Outcome | en |
dc.subject | SAGE Publications Inc. | en |
dc.title | Non-Standard Management of Target Vessels With the Inner Branch Arch Endograft: A Single-Center Retrospective Study | en |
dc.type | journalArticle | en |